These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23621841)

  • 1. Recombinant adeno-associated virus integration sites in murine liver after ornithine transcarbamylase gene correction.
    Zhong L; Malani N; Li M; Brady T; Xie J; Bell P; Li S; Jones H; Wilson JM; Flotte TR; Bushman FD; Gao G
    Hum Gene Ther; 2013 May; 24(5):520-5. PubMed ID: 23621841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival.
    Luk JM; Burchard J; Zhang C; Liu AM; Wong KF; Shek FH; Lee NP; Fan ST; Poon RT; Ivanovska I; Philippar U; Cleary MA; Buser CA; Shaw PM; Lee CN; Tenen DG; Dai H; Mao M
    J Biol Chem; 2011 Sep; 286(35):30706-30713. PubMed ID: 21737452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAV-encoded OTC activity persisting to adulthood following delivery to newborn spf(ash) mice is insufficient to prevent shRNA-induced hyperammonaemia.
    Cunningham SC; Kok CY; Spinoulas A; Carpenter KH; Alexander IE
    Gene Ther; 2013 Dec; 20(12):1184-7. PubMed ID: 24108150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver.
    Nakai H; Wu X; Fuess S; Storm TA; Munroe D; Montini E; Burgess SM; Grompe M; Kay MA
    J Virol; 2005 Mar; 79(6):3606-14. PubMed ID: 15731255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAV vector integration sites in mouse hepatocellular carcinoma.
    Donsante A; Miller DG; Li Y; Vogler C; Brunt EM; Russell DW; Sands MS
    Science; 2007 Jul; 317(5837):477. PubMed ID: 17656716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term correction of ammonia metabolism and prolonged survival in ornithine transcarbamylase-deficient mice following liver-directed treatment with adeno-associated viral vectors.
    Moscioni D; Morizono H; McCarter RJ; Stern A; Cabrera-Luque J; Hoang A; Sanmiguel J; Wu D; Bell P; Gao GP; Raper SE; Wilson JM; Batshaw ML
    Mol Ther; 2006 Jul; 14(1):25-33. PubMed ID: 16677864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice.
    Dalwadi DA; Torrens L; Abril-Fornaguera J; Pinyol R; Willoughby C; Posey J; Llovet JM; Lanciault C; Russell DW; Grompe M; Naugler WE
    Mol Ther; 2021 Feb; 29(2):680-690. PubMed ID: 33554867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis type VII mouse.
    Sferra TJ; Qu G; McNeely D; Rennard R; Clark KR; Lo WD; Johnson PR
    Hum Gene Ther; 2000 Mar; 11(4):507-19. PubMed ID: 10724030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and spectrum of genomic integration of recombinant adeno-associated virus serotype 8 vector in neonatal mouse liver.
    Inagaki K; Piao C; Kotchey NM; Wu X; Nakai H
    J Virol; 2008 Oct; 82(19):9513-24. PubMed ID: 18614641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the state of the science for adeno-associated virus integration: An integrated perspective.
    Sabatino DE; Bushman FD; Chandler RJ; Crystal RG; Davidson BL; Dolmetsch R; Eggan KC; Gao G; Gil-Farina I; Kay MA; McCarty DM; Montini E; Ndu A; Yuan J;
    Mol Ther; 2022 Aug; 30(8):2646-2663. PubMed ID: 35690906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction and prevention of severe hyperammonemia in the spfash mouse model of ornithine transcarbamylase deficiency using shRNA and rAAV-mediated gene delivery.
    Cunningham SC; Kok CY; Dane AP; Carpenter K; Kizana E; Kuchel PW; Alexander IE
    Mol Ther; 2011 May; 19(5):854-9. PubMed ID: 21386824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalent and Disseminated Recombinant and Wild-Type Adeno-Associated Virus Integration in Macaques and Humans.
    Martins KM; Breton C; Zheng Q; Zhang Z; Latshaw C; Greig JA; Wilson JM
    Hum Gene Ther; 2023 Nov; 34(21-22):1081-1094. PubMed ID: 37930949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver.
    Bell P; Moscioni AD; McCarter RJ; Wu D; Gao G; Hoang A; Sanmiguel JC; Sun X; Wivel NA; Raper SE; Furth EE; Batshaw ML; Wilson JM
    Mol Ther; 2006 Jul; 14(1):34-44. PubMed ID: 16682254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the potential for AAV vector genotoxicity in a murine model.
    Li H; Malani N; Hamilton SR; Schlachterman A; Bussadori G; Edmonson SE; Shah R; Arruda VR; Mingozzi F; Wright JF; Bushman FD; High KA
    Blood; 2011 Mar; 117(12):3311-9. PubMed ID: 21106988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of a clinical candidate AAV8 vector for ornithine transcarbamylase (OTC) deficiency reveals functional enzyme from each persisting vector genome.
    Wang L; Morizono H; Lin J; Bell P; Jones D; McMenamin D; Yu H; Batshaw ML; Wilson JM
    Mol Genet Metab; 2012 Feb; 105(2):203-11. PubMed ID: 22133298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice.
    Yang Y; Wang L; Bell P; McMenamin D; He Z; White J; Yu H; Xu C; Morizono H; Musunuru K; Batshaw ML; Wilson JM
    Nat Biotechnol; 2016 Mar; 34(3):334-8. PubMed ID: 26829317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors.
    Donsante A; Vogler C; Muzyczka N; Crawford JM; Barker J; Flotte T; Campbell-Thompson M; Daly T; Sands MS
    Gene Ther; 2001 Sep; 8(17):1343-6. PubMed ID: 11571571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Dlk1-Dio3 imprinted gene cluster noncoding RNAs as novel candidate biomarkers for liver tumor promotion.
    Lempiäinen H; Couttet P; Bolognani F; Müller A; Dubost V; Luisier R; Del Rio Espinola A; Vitry V; Unterberger EB; Thomson JP; Treindl F; Metzger U; Wrzodek C; Hahne F; Zollinger T; Brasa S; Kalteis M; Marcellin M; Giudicelli F; Braeuning A; Morawiec L; Zamurovic N; Längle U; Scheer N; Schübeler D; Goodman J; Chibout SD; Marlowe J; Theil D; Heard DJ; Grenet O; Zell A; Templin MF; Meehan RR; Wolf RC; Elcombe CR; Schwarz M; Moulin P; Terranova R; Moggs JG
    Toxicol Sci; 2013 Feb; 131(2):375-86. PubMed ID: 23091169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vector sequences are not detected in tumor tissue from research subjects with ornithine transcarbamylase deficiency who previously received adenovirus gene transfer.
    Zhong L; Li S; Li M; Xie J; Zhang Y; Lee B; Batshaw ML; Wilson JM; Gao G
    Hum Gene Ther; 2013 Sep; 24(9):814-9. PubMed ID: 24010702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Integration of AAV vectors and insertional mutagenesis].
    Rossi A; Salvetti A
    Med Sci (Paris); 2016 Feb; 32(2):167-74. PubMed ID: 26936174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.